0001479290-18-000123.txt : 20181214
0001479290-18-000123.hdr.sgml : 20181214
20181214212315
ACCESSION NUMBER: 0001479290-18-000123
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181214
FILED AS OF DATE: 20181214
DATE AS OF CHANGE: 20181214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Joshi Abhay
CENTRAL INDEX KEY: 0001359089
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36297
FILM NUMBER: 181236858
MAIL ADDRESS:
STREET 1: C/O REVANCE THERAPEUTICS, INC.
STREET 2: 7555 GATEWAY BOULEVARD
CITY: NEWARK
STATE: CA
ZIP: 94560
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Revance Therapeutics, Inc.
CENTRAL INDEX KEY: 0001479290
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770551645
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7555 GATEWAY BLVD.
CITY: NEWARK
STATE: CA
ZIP: 94560
BUSINESS PHONE: 510-742-3400
MAIL ADDRESS:
STREET 1: 7555 GATEWAY BLVD.
CITY: NEWARK
STATE: CA
ZIP: 94560
4
1
wf-form4_154484057233025.xml
FORM 4
X0306
4
2018-12-14
0
0001479290
Revance Therapeutics, Inc.
RVNC
0001359089
Joshi Abhay
C/O REVANCE THERAPEUTICS, INC.
7555 GATEWAY BOULEVARD
NEWARK
CA
94560
0
1
0
0
Chief Operating Officer
Common Stock
2018-12-14
4
F
0
4260
19.91
D
80003
D
Represents the number of shares withheld by and surrendered to the issuer on December 14, 2018, to satisfy tax withholding obligations that arose in connection with the vesting of a 2014 Restricted Stock Award ("RSA") for 8,594 shares. The RSA vests in four equal annual installments from December 14, 2016, subject to Dr. Joshi's Continuous Service (as defined in the Issuer's 2014 Inducement Plan) on each vesting date.
/s/ Gordon Ho, Attorney-in-Fact
2018-12-14